King Pharmaceuticals to resubmit Remoxy application to FDA FDA rejects biotech co.’s non-Hodgkin’s lymphoma treatment FDA approves Alimta as maintenance therapy for advanced lung cancer Biogen Idec, Acorda Therapeutics to develop, commercialize MS drug BioSante, Cell Genesys to merge Bayer, Celera to develop cancer drugs Merck KGaA launches RebiSmart Takeda completes acquisition of IDM Pharma Active ingredient in eye drug may work as hair loss treatment GSK completes acquisition of Stiefel First Previous 236 237 238
